Skip to main content
Erschienen in: Virchows Archiv 3/2018

01.02.2018 | Original Article

Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement

verfasst von: Sébastien Aubert, Amandine Berdelou, Viviane Gnemmi, Hélène Behal, Robert Caiazzo, Michèle D’herbomez, Pascal Pigny, Jean Louis Wemeau, Bruno Carnaille, Florence Renaud, Brigitte Bouchindhomme, Emmanuelle Leteurtre, Michael Perrais, François Pattou, Christine Do Cao

Erschienen in: Virchows Archiv | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Lymph node involvement (LNI) is one of the most important prognostic factors for poor survival in medullary thyroid carcinoma (MTC). At diagnosis, LNI is found in over 50% of sporadic MTCs, and especially in large tumours. Cervical lymph node dissection is therefore mandatory during MTC surgery. However, some large tumours (responsible for high preoperative basal calcitonin levels) are found to lack LNI, and can be cured definitely. Preoperative detection of these particular tumours might spare patients from undergoing extensive cervical dissection. The objective of the present retrospective study of a series of large sporadic MTCs was to identify clinical, biological and pathological factors that were predictive of LNI. Consecutive cases of large, sporadic MTCs (measuring at least 1 cm in diameter) were retrieved and reviewed. The levels of several mature microRNAs (miRs) in paraffin-embedded samples were assessed using qPCR. Of the 54 MTCs, 26 had LNI and 28 were pN0. Relative to pN0 patients, patients with LNI had a significant higher preoperative basal calcitonin level (p = 0.0074) and a greater prevalence of infiltrative margins (p < 0.0001), lymphovascular invasion (p = 0.0004), extrathyroidal extension (p < 0.0001), a higher pT stage (p = 0.0003) and more abundant desmoplastic stroma (p = 0.0006). Tumour expression levels of miR-21 (p = 0.0008) and miR-183 (p = 0.0096) were higher in the LNI group. The abundance of desmoplastic stroma (p = 0.007) and the miR-21 expression level (p = 0.0026) were independent prognostic factors for LNI. The abundance of desmoplastic stroma and high levels of miR-21 expression were strong indicators of LNI, and may thus help the surgeon to choose the extent of cervical lymph node dissection for large, sporadic MTCs with no preoperatively obvious LNI.
Literatur
1.
Zurück zum Zitat Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma et al (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567–610CrossRefPubMedPubMedCentral Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma et al (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567–610CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 2:880–887 discussion 887-888CrossRef Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 2:880–887 discussion 887-888CrossRef
3.
Zurück zum Zitat Scollo C, Baudin E, Travagli J-P, Caillou B, Bellon N, Leboulleux S, Schlumberger M (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070–2075CrossRefPubMed Scollo C, Baudin E, Travagli J-P, Caillou B, Bellon N, Leboulleux S, Schlumberger M (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070–2075CrossRefPubMed
4.
Zurück zum Zitat Gimm O (2013) Extent of surgery in clinically evident but operable MTC—when is central and/or lateral lympadenectomy indicated? Thyroid Res 6(Suppl 1):S3PubMedPubMedCentral Gimm O (2013) Extent of surgery in clinically evident but operable MTC—when is central and/or lateral lympadenectomy indicated? Thyroid Res 6(Suppl 1):S3PubMedPubMedCentral
5.
Zurück zum Zitat Machens A, Hauptmann S, Dralle H (2008) Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Surg 95:586–591CrossRefPubMed Machens A, Hauptmann S, Dralle H (2008) Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Surg 95:586–591CrossRefPubMed
12.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C, International Union against C (2009) TNM classification of malignant tumours. Wiley-Blackwell, Chichester and Hoboken Sobin LH, Gospodarowicz MK, Wittekind C, International Union against C (2009) TNM classification of malignant tumours. Wiley-Blackwell, Chichester and Hoboken
17.
Zurück zum Zitat Yip DT, Hassan M, Pazaitou-Panayiotou K, Ruan DT, Gawande AA, Gaz RD, Jr Moore FD, Hodin RA, Stephen AE, Sadow PM, Daniels GH, Randolph GW, Parangi S, Lubitz CC (2011) Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma. Surgery 150(6):1168–1177. https://doi.org/10.1016/j.surg.2011.09.043 CrossRefPubMed Yip DT, Hassan M, Pazaitou-Panayiotou K, Ruan DT, Gawande AA, Gaz RD, Jr Moore FD, Hodin RA, Stephen AE, Sadow PM, Daniels GH, Randolph GW, Parangi S, Lubitz CC (2011) Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma. Surgery 150(6):1168–1177. https://​doi.​org/​10.​1016/​j.​surg.​2011.​09.​043 CrossRefPubMed
18.
Zurück zum Zitat Koperek O, Scheuba C, Cherenko M, Neuhold N, De Micco C, Schmid KW et al (2008) Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology 52:6–630CrossRef Koperek O, Scheuba C, Cherenko M, Neuhold N, De Micco C, Schmid KW et al (2008) Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology 52:6–630CrossRef
20.
Zurück zum Zitat Scheuba C, Kaserer K, Kaczirek K, Asari R, Niederle B (2006) Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative “marker” for lymph node metastases. World J Surg 30:853–859CrossRefPubMed Scheuba C, Kaserer K, Kaczirek K, Asari R, Niederle B (2006) Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative “marker” for lymph node metastases. World J Surg 30:853–859CrossRefPubMed
21.
Zurück zum Zitat Krueger JE, Maitra A, Albores-Saavedra J (2000) Inherited medullary microcarcinoma of the thyroid: a study of 11 cases. Am J Surg Pathol 24:853–858CrossRefPubMed Krueger JE, Maitra A, Albores-Saavedra J (2000) Inherited medullary microcarcinoma of the thyroid: a study of 11 cases. Am J Surg Pathol 24:853–858CrossRefPubMed
22.
Zurück zum Zitat Machens A, Dralle H (2008) Clinical relevance of desmoplasia in medullary thyroid carcinoma. Histopathology 53:481 author reply 482-483CrossRefPubMed Machens A, Dralle H (2008) Clinical relevance of desmoplasia in medullary thyroid carcinoma. Histopathology 53:481 author reply 482-483CrossRefPubMed
Metadaten
Titel
Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement
verfasst von
Sébastien Aubert
Amandine Berdelou
Viviane Gnemmi
Hélène Behal
Robert Caiazzo
Michèle D’herbomez
Pascal Pigny
Jean Louis Wemeau
Bruno Carnaille
Florence Renaud
Brigitte Bouchindhomme
Emmanuelle Leteurtre
Michael Perrais
François Pattou
Christine Do Cao
Publikationsdatum
01.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 3/2018
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-018-2303-7

Weitere Artikel der Ausgabe 3/2018

Virchows Archiv 3/2018 Zur Ausgabe

Neu im Fachgebiet Pathologie